Citrinamides, new potentiators of antifungal miconazole activity, produced by Penicillium sp. FKI-1938

Journal of Antibiotics

Volumn 61, Issue 9, 2008, Pages 550-555

  Fukuda, Takashi ^a   Hasegawa, Yoko ^a   Sakabe, Yasunari ^a   Tomoda, Hiroshi ^a   Omura, Satoshi ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Candida albicans; Citrinamide; Miconazole potentiator; Penicillium sp.Fungal metabolite

Indexed keywords

ALKALOID DERIVATIVE; CITRINAMIDE A; CITRINAMIDE B; MICONAZOLE; UNCLASSIFIED DRUG;

AMINO ACID ANALYSIS; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CARBON NUCLEAR MAGNETIC RESONANCE; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DRUG ISOLATION; DRUG POTENCY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; PENICILLIUM; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SOLVENT EXTRACTION; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION;

ANILIDES; ANTIFUNGAL AGENTS; DRUG SYNERGISM; FERMENTATION; GLUTAMINE; MICONAZOLE; PENICILLIUM;

CANDIDA ALBICANS; PENICILLIUM; PENICILLIUM SP.;

EID: 57849148701     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.1038/ja.2008.73     Document Type: Article

References (13)

1. Nishiyama Y, Yamaguchi H. Mode of action of antifungal agents for treatment of systematic fungal infection. Antibiot Chemother 16: 19-26 (2000)
2. Walsh TJ, Kasai M, Francesconi A, Landsman D, Chanock SJ. New evidence that Candida albicans possesses additional ATP-binding cassette MDR-like genes: implications for antifungal azole resistance. J Med Vet Mycol 35: 133-137 (1997)
3. Fling ME, Kopf J, Tamarkin A, Gorman JA, Smith HA, Koltin Y. Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate. Mol Gen Genet 227: 318-329 (1991)
4. Vanden BH, Marichal P, Gorrens J, Bellens D, Moereels H, Janssen PA. Mutation in cytochrome-P-450-dependent 14α-demethylase results in decreased affinity for azole antifungals. Bio Chem Soc Trans 18: 56-59 (1990)
5. Ōmura S. Antiinfective drugs into the 21st century. Nippon Saikingaku Zasshi 54: 795-813 (1999)
6. Arai M, Tomoda H, Okuda T, Wang H, Tabata N, Masuma R, Yamaguchi Y, Ōmura S. Funicone-related compounds, potentiators of antifungal miconazole activity, prodused by Talaromyces flavus FKI-0067. J Antibiot 55: 172-180 (2002)
7. Fukuda T, Arai M, Yamaguchi Y, Masuma R, Tomoda H, Ōmura S. New beauvericins, potentiators of antifungal miconazole activity, produced by Beauveria sp. FKI-1366. I. Taxonomy, fermentation, isolation, and biological properties. J Antibiot 57: 110-116 (2004)
8. Fukuda T, Yamaguchi Y, Masuma R, Tomoda H, Ōmura S. Citridones, potentiators of antifungal miconazole activity, produced by Penicillium sp. FKI-1938 I. Taxonomy, fermentation, isolation, and biological properties. J Antibiot 58: 309-314 (2005)
9. Fukuda T, Sakabe Y, Tomoda H, Ōmura S. Fungal citridone D having a novel phenylfuropyridine skeleton. Chem Pharm Bull 54: 1659-1661 (2006)
10. Fukuda T, Hasegawa Y, Hagimori K, Yamaguchi Y, Masuma R, Tomoda H, Ōmura S. Tensidols, new potentiators of antifungal miconazole activity, produced by Aspergillus niger FKI-2342. J Antibiot 59: 480-485 (2006)
11. Fukuda T, Matsumoto A, Takahashi Y, Tomoda H, Ōmura S. Phenatic acids A and B, new potentiators of antifungal miconazole activity produced by Streptomyces sp. K03-0132. J Antibiot 58: 252-259 (2005)
12. National Committee Clinical Laboratory Standards. Approved Standard M27-A. NCCLS Villanova PA. (1997)
13. White TC. Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob Agents Chemother 41: 1482-1487 (1997)